Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $23.00

Sabra Healthcare REIT (NASDAQ:SBRA) had its price objective raised by Citizens Jmp from $22.00 to $23.00 in a research note released on Wednesday,Benzinga reports. Citizens Jmp currently has a market outperform rating on the real estate investment trust’s stock.

Several other research firms have also issued reports on SBRA. Wells Fargo & Company raised their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Tuesday, November 25th. Wall Street Zen cut shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. UBS Group started coverage on Sabra Healthcare REIT in a report on Tuesday, November 18th. They issued a “neutral” rating and a $20.00 price objective for the company. Truist Financial raised their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a research note on Tuesday, January 20th. Finally, Cantor Fitzgerald lifted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Tuesday. Five research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and an average price target of $21.70.

Sabra Healthcare REIT Stock Performance

NASDAQ:SBRA opened at $19.93 on Wednesday. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. The company has a market capitalization of $5.03 billion, a P/E ratio of 31.14, a P/E/G ratio of 1.61 and a beta of 0.67. Sabra Healthcare REIT has a 1 year low of $15.60 and a 1 year high of $20.70. The business has a fifty day simple moving average of $19.14 and a two-hundred day simple moving average of $18.83.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The business had revenue of $201.35 million for the quarter, compared to analysts’ expectations of $201.97 million. During the same quarter in the previous year, the company posted $0.36 earnings per share. The business’s quarterly revenue was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, analysts expect that Sabra Healthcare REIT will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Friday, February 13th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.0%. Sabra Healthcare REIT’s payout ratio is 187.50%.

Institutional Investors Weigh In On Sabra Healthcare REIT

Institutional investors and hedge funds have recently bought and sold shares of the business. Rothschild Investment LLC grew its holdings in Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 889 shares in the last quarter. Smartleaf Asset Management LLC boosted its position in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 714 shares during the last quarter. Founders Capital Management purchased a new position in shares of Sabra Healthcare REIT in the third quarter valued at $28,000. Strengthening Families & Communities LLC purchased a new position in shares of Sabra Healthcare REIT in the fourth quarter valued at $29,000. Finally, Danske Bank A S bought a new stake in Sabra Healthcare REIT in the third quarter worth $30,000. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.